NEW YORK, NY — On October 13, as the sun dips below the horizon, a profound transformation will sweep across the globe. More than 325 iconic landmarks—from the towering spires of New York’s One World Trade Center to the mist-shrouded expanse of Niagara Falls—will be bathed in a rhythmic glow of teal, green, and pink. This is not merely a display of architectural beauty; it is a global rallying cry for National Metastatic Breast Cancer (MBC) Awareness Day, a campaign designed to pull a terminal disease out of the shadows and into the harsh light of scientific scrutiny.
Led by the non-profit organization METAvivor Research and Support, the #LightUpMBC campaign seeks to rectify a persistent imbalance in the breast cancer narrative. While October is widely recognized as Breast Cancer Awareness Month, advocates argue that the focus often centers on early detection and survivorship, frequently leaving the reality of Stage 4 metastatic breast cancer—a condition for which there is currently no cure—under-discussed and under-funded.
The Reality of Stage 4: Defining the "Other" Breast Cancer
To understand the urgency behind #LightUpMBC, one must first grasp the clinical reality of metastatic breast cancer. MBC occurs when breast cancer cells migrate from the primary site in the breast to distant organs, most commonly the bones, liver, lungs, or brain. Despite this spread, it remains categorized as breast cancer, governed by its site of origin rather than the organs it invades.
For patients, the diagnosis is life-altering. Some are diagnosed at Stage 4 from the very beginning, while others find themselves confronting a recurrence years or even decades after completing treatment for early-stage disease. Unlike localized cancer, which may be treated with the hope of being "cured," MBC is a chronic, life-limiting condition. Treatment is a lifelong, relentless pursuit—a cycle of therapies, scans, and adjustments.
Even when a patient achieves "No Evidence of Disease" (NED), the cancer is rarely gone; it is merely managed. As the disease progresses, it often develops resistance to current drug regimens, forcing patients to pivot to new treatments in a race against time. The statistics are sobering: in the United States alone, an estimated 42,670 people are expected to lose their lives to breast cancer in 2026—a rate of approximately 117 deaths every single day.
A Chronology of Advocacy: From a Single Light to a Global Movement
The #LightUpMBC movement was born not in a boardroom, but in a bond of friendship. Its origins trace back to the vision of Jessica Moore, who, while battling the disease at age 36, harbored a simple, powerful dream: to see one local landmark illuminated to honor the thousands living with the metastatic diagnosis.
Following Moore’s untimely passing, her friend Laura Inahara took up the torch, transforming that singular wish into an international phenomenon.
- 2017: The movement achieves its first major milestone when the Memorial Bridge in Portsmouth, New Hampshire, becomes the first landmark to light up in the official MBC colors of teal, green, and pink.
- 2018–2024: The campaign gains momentum, expanding across state lines and eventually crossing international borders. The logistical effort to coordinate lighting across different time zones, municipal regulations, and cultures becomes a testament to the dedication of the MBC community.
- 2026: The campaign reaches its most ambitious scale yet, encompassing 325 landmarks across all 50 U.S. states, 20 countries, and 195 cities.
This rapid expansion reflects a growing recognition that the "pink ribbon" narrative, while successful in raising awareness for general breast cancer, has historically failed to address the specific, urgent needs of the metastatic community.
Scientific Rigor and the Funding Gap
At the heart of the #LightUpMBC initiative is a clear, financial objective: to fund research. METAvivor distinguishes itself from other breast cancer organizations by dedicating 100% of its research grants exclusively to Stage 4 metastatic breast cancer.
The organization employs a rigorous "scientific peer and patient advocate" review process. By ensuring that both top-tier researchers and patients living with the disease have a seat at the table during the grant selection process, METAvivor ensures that the research funded is not only scientifically sound but also clinically meaningful to those whose lives depend on it.
The stakes are high. As Dr. Kelly Shanahan, METAvivor Board President and a long-term MBC patient, notes, the research landscape is at a critical juncture. "When I was diagnosed with metastatic breast cancer in 2013, I certainly didn’t think I’d still be here 13 years later," Dr. Shanahan says. "My hope and the hope of so many others lies in research. #LightUpMBC is the biggest contributor to this research, and it is also a way to bring us together as a community."
To date, the campaign has raised over $2.7 million for research—a vital infusion of capital into a field that has historically seen a smaller share of the "pink" funding pool compared to early-stage research.
Official Responses and the #LightUpMBC Live Broadcast
The pinnacle of the campaign is the #LightUpMBC Live event, a broadcast designed to bridge the gap between scientific advancement and human experience. Airing on October 13 at 8 p.m. ET / 5 p.m. PT, the event will be hosted by Tami Eagle Bowling—who has lived with MBC for 11 years—and Broadway performer and breast cancer survivor Kara Lindsay.
The broadcast promises a unique blend of advocacy and entertainment. Viewers can expect:
- Patient Narratives: Raw, personal stories broadcast directly from the sites of illuminated landmarks, humanizing the statistics.
- Scientific Insight: Expert commentary on the latest breakthroughs in oncology and the future of treatment resistance studies.
- Artistic Tribute: Musical performances from Broadway luminaries, including two-time Tony Award winner Victoria Clark and Tony Award nominee Dorian Harewood, alongside actress Christina Bianco and singer-songwriter Cassandra Kubinski.
The event will be available for free on the METAvivor YouTube channel, Facebook Live, and the LiveOne platform. By providing a virtual space for this global community to gather, the event serves to dissolve the isolation often felt by those living with a terminal diagnosis.
The Implications: Moving Beyond Awareness to Action
The success of #LightUpMBC carries significant implications for the future of cancer advocacy. It demonstrates that patients are no longer content to be passive recipients of care; they are active architects of their own survival.
The campaign forces society to confront a uncomfortable reality: that "awareness" without "research" is insufficient. By demanding that landmarks—the symbols of our cities and our history—be transformed to represent the MBC community, the movement forces a public conversation about the difference between managing a disease and curing it.
Furthermore, the global nature of the campaign highlights the universal struggle of the MBC patient. Whether in Inverness, Scotland, or Cebu, Philippines, the challenges of access to care, treatment side effects, and the psychological weight of a Stage 4 diagnosis are shared experiences. The #LightUpMBC campaign has successfully created a global network of solidarity that transcends borders.
As the lights turn on this October 13, the goal is simple: to make the invisible visible. The campaign organizers urge the public to photograph these landmarks and share them on social media using the hashtags #LightUpMBC and #METAvivor. Every post, every share, and every dollar donated serves as a reminder that for the millions of people living with metastatic breast cancer, the fight is not over—and it is a fight that the entire world is now being asked to join.
For those interested in contributing to this life-saving research, or for a full list of participating landmarks and broadcast details, visit www.lightupmbc.org. As the campaign founders often emphasize, every light ignited is a step closer to turning a terminal diagnosis into a survivable condition.
About the Author
